Bicuspid aortic valve (BAV) is the most common adult congenital heart defect and is found in 0.5% to 2.0% of the general population. The term "BAV" refers to a heterogeneous group of disorders characterized by diverse aortic valve malformations with associated aortopathy, congenital heart defects, and genetic syndromes. Even after decades of investigation, the genetic determinants of BAV and its complications remain largely undefined. Just as BAV phenotypes are highly variable, the genetic etiologies of BAV are equally diverse and vary from complex inheritance in families to sporadic cases without any evidence of inheritance. In this paper, the authors discuss current concepts in BAV genetics and propose a roadmap for unraveling unanswered questions about BAV through the integrated analysis of genetic and clinical data. (J Am Coll Cardiol 2014;64:832-9)
T he most common adult congenital heart defect, a bicuspid aortic valve (BAV), is found in 0.5% to 2.0% of the general population (1, 2) , with a higher prevalence in men. BAVs result from abnormal aortic cusp formation during valvulogenesis, in which adjacent cusps fuse into a single cusp that is bigger than its counterpart but smaller than 2 normal cusps combined (2) . Overall, "BAV" refers to a heterogeneous group of disorders distinguished by aortic valve malformations with associated aortopathy, congenital heart defects, and genetic syndromes. Despite years of investigation,
researchers have yet to define genetic determinants of BAV and its complications, although most patients with BAV will develop complications requiring treatment. Just as BAV phenotypes are highly variable, the genetic etiologies of BAV are equally diverse and vary from complex inheritance in families to sporadic cases without evidence of inheritance (3).
CURRENT KNOWLEDGE OF THE GENETICS
OF BICUSPID AORTIC VALVE GENETIC SYNDROMES. Although most patients with BAV have no extracardiac abnormalities, BAV also occurs as a component of known genetic syndromes ( Table 1 ). The highest penetrance of BAV for a genetic syndrome occurs in women with Turner syndrome, which is caused by partial or complete absence of one X chromosome in women. BAV appears in >30% of women with Turner syndrome, and the prevalence of associated coarctation, aortic aneurysms, and acute aortic dissections exceeds that in sporadic BAV cases (4) . In the general population, BAV is more prevalent in men (1% to 2%) than women (0.5%) (5) , suggesting that the loss of genes on the X chromosome may predispose to BAV formation. The genes responsible for this effect have not been identified.
CONGENITAL HEART DEFECTS. Although the genetic links remain unknown, BAV is also seen with some congenital heart disorders involving the left ventricular outflow tract (LVOT), such as hypoplastic left heart syndrome, coarctation of the aorta, and some ventricular septal defects (6) (7) (8) . Hypoplastic left heart syndrome and coarctation are significantly enriched among primary relatives of patients with BAV, and according to linkage analysis, mutations in the same genes probably caused some cases of hypoplastic left heart syndrome and BAV (9) . One possible interpretation of these observations is that LVOT morphology and obstruction may also influence aortic valve development because of alterations in blood flow or shear stress (10) . Inheritance is observed in >50% of families if associated nonvalvular complications are involved, such as aortic coarctation, thoracic aortic aneurysms, and mitral valve or ventricular septal defects, which are each found in 10% of family members (14) . The heritability of BAV has been estimated to be as high as 0.89 in these studies, and multiple genetic alleles can interact to cause BAV or different congenital heart defects without BAV in the same family. Genetic, cloning strategies, but it is unlikely to cause more than a small proportion of familial cases (17, 18) .
In families with inherited BAV, the mutated gene often correlates with specific features and prognosis.
ACTA2 mutations cause a syndrome that may include BAV as well as thoracic aortic aneurysms, premature coronary artery disease, and cerebrovascular disease (19) . NOTCH1 mutations predispose to BAV with calcific aortic stenosis but are not associated with aortic disease or other extracardiac abnormalities.
BAV occurs in 20% of cases of Loeys-Dietz syndrome, associated with craniofacial defects and connective tissue fragility with vulnerability to acute arterial dissections (20) . Therefore, knowledge of the particular mutation in a family can direct clinicians to screen for additional clinical features in the proband and family members. As more BAV genes are discovered, genetic information will increasingly influence clinical decisions about diagnostic tests and therapies for patients with BAV.
Studies involving large cohorts of patients with BAV and thoracic aortic disease indicate that many types of genetic variation contribute to the risk for this complex disease, from common single-nucleotide polymorphisms to rare copy-number variants and chromosomal abnormalities (Fig. 1A) . Mutations in the same gene appear to cause TAAD across an allelic Fig. 2A) . The ability to sequence entire exomes or genomes of multiple family members has greatly reduced the time and labor required for gene discovery and has led to the discovery of several novel genes for TAAD (21, (36) (37) (38) (39) .
Even if BAV inheritance is not observed, genetic tests of family members may still be informative.
Genetic variants present in affected children but not their parents are referred to as de novo variants (Fig. 2B) , which are generally prioritized because they tend to be more deleterious than inherited variations (40) . Recent trio-based exome sequencing studies identified causal de novo mutations in several rare syndromes that are not inherited in families (41, 42) .
Because dozens of de novo variants arise stochastically in each generation, candidate genes with de novo variants need to be validated by performing mutation analysis of independent groups of cases.
In contrast to families with inherited BAV disease, >80% of patients with BAV have no known affected relatives and are regarded as sporadic cases. Because "Knock-out" models include tissue-specific and whole-organism deletion of genes.
"Knock-in" models are generated by introducing a specific human sequence variant into an orthologous gene. In real time, these processes would most likely occur simultaneously.
CNV ¼ central nervous system; GWA ¼ genome-wide analysis.
Prakash et al.
linkage analysis is unfeasible to investigate single genetic variants in unrelated patients, case-control association methods such as GWA studies must be used (Fig. 2C) . GWA studies typically require thou- 
